Adjuvant corticosteroid treatment in adults with influenza a (H7N9) viral pneumonia

Critical Care Medicine

Volumn 44, Issue 6, 2016, Pages e318-e328

  Cao, Bin ^a,s   Gao, Hainv ^b   Zhou, Boping ^c   Deng, Xilong ^d   Hu, Chengping ^e   Deng, Chaosheng ^f   Lu, Hongzhou ^g   Li, Yuping ^h   Gan, Jianhe ⁱ   Liu, Jingyuan ^j   Li, Hui ^a   Zhang, Yao ^k   Yang, Yida ^b   Fang, Qiang ^b   Shen, Yinzhong ^g   Gu, Qin ^l   Zhou, Xianmei ^m   Zhao, Wei ⁿ   Pu, Zenghui ^o   Chen, Ling ^p   Sun, Baoxia ^q   Liu, Xi ^c   Hamilton, Carol Dukes ^r   Li, Lanjuan ^b   more..

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY   (China)

^c SHENZHEN THIRD PEOPLE S HOSPITAL   (China)

^d Guangzhou Eighth People's Hospital   (China)

^e CENTRAL SOUTH UNIVERSITY   (China)

^f FUJIAN MEDICAL UNIVERSITY   (China)

^g FUDAN UNIVERSITY   (China)

^h WENZHOU MEDICAL UNIVERSITY   (China)

ⁱ MEDICAL COLLEGE OF SOOCHOW UNIVERSITY   (China)

^j CAPITAL MEDICAL UNIVERSITY   (China)

^k FAMILY HEALTH INTERNATIONAL   (United States)

^l NANJING UNIVERSITY   (China)

^m AFFILIATED HOSPITAL OF NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

ⁿ SOUTHEAST UNIVERSITY   (China)

^o YANTAI YUHUANGDING HOSPITAL   (China)

^p ZUNYI MEDICAL UNIVERSITY   (China)

^q Zaozhuang Municipal Hospital   (China)

^r DUKE UNIVERSITY   (United States)

^s CHINA JAPAN FRIENDSHIP HOSPITAL   (China)

more..

Author keywords

corticosteroid; influenza A; mortality; nosocomial infection; viral shedding; virus

Indexed keywords

CORTICOSTEROID; DEXAMETHASONE; HYDROCORTISONE; METHYLPREDNISOLONE; ANTIVIRUS AGENT;

ADJUVANT THERAPY; ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; FEMALE; HOSPITAL INFECTION; HOSPITAL MORTALITY; HUMAN; HYPOXEMIA; INFLUENZA A VIRUS (H7N9); LUNG INFILTRATE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TREATMENT DURATION; VIRUS PNEUMONIA; VIRUS SHEDDING; CASE CONTROL STUDY; CHINA; COMBINATION DRUG THERAPY; COMPLICATION; DRUG EFFECTS; EPIDEMIOLOGY; INFLUENZA, HUMAN; MIDDLE AGED; MORTALITY; PNEUMONIA, VIRAL; PROPENSITY SCORE; PROPORTIONAL HAZARDS MODEL; TIME FACTOR; VERY ELDERLY; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; AGED; AGED, 80 AND OVER; ANTIVIRAL AGENTS; CASE-CONTROL STUDIES; CHINA; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INFLUENZA A VIRUS, H7N9 SUBTYPE; INFLUENZA, HUMAN; MALE; MIDDLE AGED; PNEUMONIA, VIRAL; PROPENSITY SCORE; PROPORTIONAL HAZARDS MODELS; TIME FACTORS; VIRUS SHEDDING; YOUNG ADULT;

EID: 84959270673     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0000000000001616     Document Type: Article

References (36)

1. Gao R Cao B Hu Y Human infection with a novel avian-origin influenza A (H7N9) virus. N Engl J Med 2013 368 1888 1897
2. Chen Y Liang W Yang S Human infections with the emerging avian influenza A H7N9 virus from wet market poultry: Clinical analysis and characterisation of viral genome. Lancet 2013 381 1916 1925
3. Uyeki TM Cox NJ Global concerns regarding novel influenza A (H7N9) virus infections. N Engl J Med 2013 368 1862 1864
4. Gao HN Lu HZ Cao B Clinical findings in 111 cases of influenza A (H7N9) virus infection. N Engl J Med 2013 368 2277 2285
5. Zhou J Wang D Gao R Biological features of novel avian influenza A (H7N9) virus. Nature 2013 499 500 503
6. Itoh Y Shinya K Kiso M In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature 2009 460 1021 1025
7. Mauad T Hajjar LA Callegari GD Lung pathology in fatal novel human influenza A (H1N1) infection. Am J Respir Crit Care Med 2010 181 72 79
8. Carter MJ A rationale for using steroids in the treatment of severe cases of H5N1 avian influenza. J Med Microbiol 2007 56 875 883
9. Brun-Buisson C Richard JC Mercat A REVA-SRLF A/H1N1v 2009 Registry Group Early corticosteroids in severe influenza A/H1N1 pneumonia and acute respiratory distress syndrome. Am J Respir Crit Care Med 2011 183 1200 1206
10. Kim SH Hong SB Yun SC Korean Society of Critical Care Medicine H1N1 Collaborative Corticosteroid treatment in critically ill patients with pandemic influenza A/H1N1 2009 infection: Analytic strategy using propensity scores. Am J Respir Crit Care Med 2011 183 1207 1214
11. Martin-Loeches I Lisboa T Rhodes A ESICM H1N1 Registry Contributors Use of early corticosteroid therapy on ICU admission in patients affected by severe pandemic (H1N1)v influenza A infection. Intensive Care Med 2011 37 272 283
12. Rodrigo C Leonardi-Bee J Nguyen-Van-Tam JS Effect of corticosteroid therapy on influenza-related mortality: A systematic review and meta-Analysis. J Infect Dis 2015 212 183 194
13. Li Q Zhou L Zhou M Epidemiology of human infections with avian influenza A(H7N9) virus in China. N Engl J Med 2014 370 520 532
14. Ranieri VM Rubenfeld GD Thompson BT Acute respiratory distress syndrome: The Berlin definition. JAMA 2012 307 2526 2533
15. Woodhead M Blasi F Ewig S Joint Taskforce of the European Respiratory Society and European Society for Clinical Microbiology and Infectious Diseases Guidelines for the management of adult lower respiratory tract infections-summary. Clin Microbiol Infect 2011 17 Suppl 6 1 24
16. Dellinger RP Levy MM Rhodes A Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med 2013 39 165 228
17. Tang BM Craig JC Eslick GD Use of corticosteroids in acute lung injury and acute respiratory distress syndrome: A systematic review and meta-Analysis. Crit Care Med 2009 37 1594 1603
18. Chinese Thoracic Society Guideline of diagnosis and treatment of community acquired pneumonia. Chin J Tuberc Respir Dis 2006 29 651 655. (article in Chinese)
19. Garner JS Jarvis WR Emori TG CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988 16 128 140
20. De Pauw B Walsh TJ Donnelly JP European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group; National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008 46 1813 1821
21. Wang C Yu H Horby PW Comparison of patients hospitalized with influenza A subtypes H7N9, H5N1, and 2009 pandemic H1N1. Clin Infect Dis 2014 58 1095 1103
22. Diaz E Martin-Loeches I Canadell L H1N1 SEMICYUC-CIBERES-REIPI Working Group (GETGAG) Corticosteroid therapy in patients with primary viral pneumonia due to pandemic (H1N1) 2009 influenza. J Infect 2012 64 311 318
23. Li F Chen G Wang J A case-control study on risk factors associated with death in pregnant women with severe pandemic H1N1 infection. BMJ Open 2012 2 e000827. doi:10.1136/bmjopen-2012-000827
24. Linko R Pettilä V Ruokonen E FINNH1N1-STUDY GROUP Corticosteroid therapy in intensive care unit patients with PCR-confirmed influenza A(H1N1) infection in Finland. Acta Anaesthesiol Scand 2011 55 971 979
25. Mady A Ramadan OS Yousef A Clinical experience with severe 2009 H1N1 influenza in the intensive care unit at King Saud Medical City, Saudi Arabia. J Infect Public Health 2012 5 52 56
26. Sertogullarindan B Ozbay B Gunini H Clinical and prognostic features of patients with pandemic 2009 influenza A (H1N1) virus in the intensive care unit. Afr Health Sci 2011 11 163 170
27. Viasus D Paño-Pardo JR Cordero E Novel Influenza A (H1N1) Study Group, Spanish Network for Research in Infectious Diseases Effect of immunomodulatory therapies in patients with pandemic influenza A (H1N1) 2009 complicated by pneumonia. J Infect 2011 62 193 199
28. Xi X Xu Y Jiang L Hospitalized adult patients with 2009 influenza A(H1N1) in Beijing, China: Risk factors for hospital mortality. BMC Infect Dis 2010 10 256. doi: 10.1186/1471-2334-10-256
29. Lamontagne F Briel M Guyatt GH Corticosteroid therapy for acute lung injury, acute respiratory distress syndrome, and severe pneumonia: A meta-Analysis of randomized controlled trials. J Crit Care 2010 25 420 435
30. Boudreault AA Xie H Leisenring W Impact of corticosteroid treatment and antiviral therapy on clinical outcomes in hematopoietic cell transplant patients infected with influenza virus. Biol Blood Marrow Transplant 2011 17 979 986
31. Hu Y Lu S Song Z Association between adverse clinical outcome in human disease caused by novel influenza A H7N9 virus and sustained viral shedding and emergence of antiviral resistance. Lancet 2013 381 2273 2279
32. Rice TW Rubinson L Uyeki TM NHLBI ARDS Network Critical illness from 2009 pandemic influenza A virus and bacterial coinfection in the United States. Crit Care Med 2012 40 1487 1498
33. Löwenberg M Stahn C Hommes DW Novel insights into mechanisms of glucocorticoid action and the development of new glucocorticoid receptor ligands. Steroids 2008 73 1025 1029
34. Lim WS Brittain C Duley L Blinded randomised controlled trial of low-dose Adjuvant Steroids in Adults admitted to hospital with Pandemic influenza (ASAP): A trial 'in hibernation', ready for rapid activation. Health Technol Assess 2015 19 1 78, vii
35. Torres A Sibila O Ferrer M Effect of corticosteroids on treatment failure among hospitalized patients with severe community-Acquired pneumonia and high inflammatory response: A randomized clinical trial. JAMA 2015 313 677 686
36. Blum CA Nigro N Briel M Adjunct prednisone therapy for patients with community-Acquired pneumonia: A multicentre, double-blind, randomised, placebo-controlled trial. Lancet 2015 385 1511 1518